about
Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's...
Read More
43.68
-2.21
(-4.82%)
367.6K
XNAS Volume
XNAS 07 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Kodiak Sciences Inc is on 14 May 2026 for the purpose of Kodiak Sciences Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bullish
Kodiak Sciences Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..